AnteBC - Cancer Risk Test

A genetic test that determines the polygenic risk score and evaluates the individual risk of a woman being tested for breast cancer. This next-generation test is based on data from genetics and statistical sciences. The genetic analysis team provides a comprehensive interpretation of the test results, indicating identified mutations (single nucleotide polymorphisms, SNPs) and, by summing the effects of risk-increasing and risk-decreasing mutations, providing a polygenic risk assessment for the type of cancer being tested. The patient's risk is compared to the average risk of patients in their age group, thus overcoming the gaps of conventional health screening programs that are based solely on the patient's age but do not consider individual risk factors. The test result report includes medical recommendations: the required frequency of specialized screenings, recommended methods for reducing cancer risk, including the use of individualized preparations.

The goal of the AnteBC test is to reduce the risk of early mortality from breast cancer by applying advanced cancer screening methods and other preventive measures.

Recommended age to perform the test: recommended for women aged 30-75 years.

Sample: oral mucosa swab.

Turnaround time after reaching the laboratory: 3 - 6 weeks.